Early-onset GI cancers diagnosed before age 50 are rising at alarming rates worldwide, underscoring the need for enhanced ...

President Trump on Thursday sent letters to 17 of the world’s largest drug companies, telling them to take more steps to ...

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...

GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

The remainder of 2025 will be busy for Vir Biotechnology as it strives to successfully pivot to developing cancer and infectious disease therapies.

IT shares extended losses for the second consecutive trading session At 11:30 IST, the barometer index, the S&P BSE Sensex declined 209.52 points or 0.26% to 80,977.23. The Nifty 50 index lost 75.85 ...

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

Leading the pack is ITC Ltd, the diversified FMCG-to-cigarettes conglomerate, which is expected to post steady growth driven ...

Adani Power, Tata Power, UPL, Godrej Properties, ITC, MCX, Narayana Hrudayalaya, , Alivus Life Sciences, Aditya Vision, Capri Global Capital, Delhivery, Dhanuka Agritech, GlaxoSmithKline ...

A single dose of RSVPreF3 OA offered protection against RSV-related lower respiratory tract disease across three RSV seasons ...